Technology and collaboration are transforming the way medicines reach patients. Discover how global regulators and the life science industry are proving that secure cloud platforms can make submissions faster, smarter, and more connected across regions.

Global submissions made simple

For decades, the vision of submitting once to multiple regulators seemed far away. This conversation between leaders from Boehringer Ingelheim, DNA Nexus, and Implement Consulting Group explores how technology and collaboration can turn that dream into reality. Viewers will learn how shared cloud environments connect regulators and industry to speed up reviews and improve global access to treatments.

The power of collaboration

Project PRISM and Project Cryptics show that global submission processes can be both secure and efficient. Through cloud-based collaboration, health authorities and companies can now review, share, and validate data in real time. This innovative approach shortens timelines, reduces duplication, and allows experts to focus on what truly matters—getting life-saving medicines to patients faster.

Proving the dream possible

The teams behind these initiatives demonstrated full end-to-end regulatory submissions across multiple agencies in just six weeks. By leveraging mature platforms like Precision FDA and Trusted Regulatory Spaces, they proved that technology is not the barrier. The result is a blueprint for global collaboration and a new standard for how innovation can accelerate access to healthcare.